EASL Studio Season 5 Special Edition

26 September at 18:00 CEST

Highlights from the EASL SLD Summit 2023

Learn moreRe-watch the last episode

EASL SLD Summit 2023

Now on-demand!

For registered delegates only.

Access now!

EASL Policy Dialogues

Season 2 Episode 6 now available!

Diagnosing Steatotic Liver Disease – Challenges and opportunities

Watch nowRe-watch the last episode

EASL Journal Club

31 October, 18:00 CET

Inflamed and non-inflamed class of HCC: A revised immunogenomic classification

RegisterSee all EASL Journal Club

EASL Molecular Tumour Board

Now on demand!

Watch the first EASL-MTB on intrahepatic cholangiocarcinoma

Watch now
    Topics

    Basic Science

    846 Resources
    2 Languages
    View

    Cirrhosis & Complications

    1491 Resources
    5 Languages
    View

    General Hepatology

    2632 Resources
    4 Languages
    View

    Immune-Mediated and Cholestatic Diseases

    640 Resources
    3 Languages
    View

    Liver Tumours

    1924 Resources
    3 Languages
    View

    Metabolism, Alcohol & Toxicity

    2667 Resources
    6 Languages
    View

    Viral Hepatitis

    2150 Resources
    13 Languages
    View
      EASL Campus Connect
      Gamification
      Journal Club
      News & articles
      You may also be interested in

      Online Courses

      Discover the eLearning offering and obtain up to 40 CME credits!

      View

      EASL Molecular Tumour Board on intrahepatic cholangiocarcinoma

      This EASL-MTB was held on 23 May 2023 and discussed a clinical case of intrahepatic cholangiocarcinoma (CCA).

      View

      EASL Journal Club

      Look at all the Journal Clubs available so far and continue the discussion with the community!

      View

      Basic Techniques in Experimental Hepatology at a Glance

      Lean more about this educational offering illustrating scientific video protocols in the fields of hepatology and liver-related research. 

      View

        EASL Campus is supported by:

        • GSK

        • Boehringer Ingelheim

        GSK and Boehringer Ingelheim have had no input into the EASL content of EASL Campus.